Daniel Neville
Known title: Chief Executive OfficerCIK: 0001998952
Daniel Neville's purchase track record
How the stock did after each of Daniel Neville's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since March 14, 2025
Stock higher 6 months later
20%
3 months: 0%
Median 6-month return
-28.8%
3 months: -28.6%
Beat the S&P 500
20%
median -45.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2025 | AFCG | $48K | -19.5% | +22.5% | +11.1% |
| 9/8/2025 | AFCG | $55K | -36.6% | -41.4% | +4.6% |
| 8/25/2025 | AFCG | $40K | -30.9% | -44.3% | +6.2% |
| 3/26/2025 | AFCG | $62K | -21.6% | -28.8% | +16.2% |
| 3/14/2025 | AFCG | $301K | -28.6% | -24.9% | +16.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AFCG | ▲ Buy | Grant | 91,240 | $250K | 11/20/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 17,000 | $48K | 11/18/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 12,388 | $55K | 9/8/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 10,000 | $40K | 8/25/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 5,000 | $31K | 3/28/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 5,000 | $31K | 3/26/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 16,250 | $103K | 3/17/2025 | View on chart |
| AFCG | ▲ Buy | Open Market | 30,349 | $198K | 3/14/2025 | View on chart |
| AFCG | ▲ Buy | Grant | 47,789 | $400K | 2/25/2025 | View on chart |
| AFCG | ▲ Buy | Grant | 82,873 | $750K | 12/20/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Advanced Flower Capital Reports Q2 2026 Earnings
Advanced Flower Capital released its Q2 2026 earnings conference call transcript. The company is currently trading near the middle of its 52-week price range. Recent trading activity has shown a spike in volume, indicating increased market interest in the stock following the financial update.
Advanced Flower Capital Reports Q2 2026 Earnings. Advanced Flower Capital released its Q2 2026 earnings conference call transcript. The company is currently trading near the middle of its 52-week price range. Recent trading activity has shown a spike in volume, indicating increased market interest in the stock following the financial update.